Schwedhelm, Edzard

Pharmacokinetic and pharmacodynamic properties of oral L‐citrulline and L‐arginine: impact on nitric oxide metabolism

Schwedhelm, E., Maas, R., Freese, R., Jung, D., Lukacs, Z., Jambrecina, A., Spickler, W., Schulze, F., & Böger, R. H. (2008) · British Journal of Clinical Pharmacology

Nitric Oxide and Endothelin EffectsCardiovascular Health and Disease Prevention

Cited by 494

Plasma Asymmetric Dimethylarginine and Incidence of Cardiovascular Disease and Death in the Community

Böger, R. H., Sullivan, L. M., Schwedhelm, E., Wang, T. J., Maas, R., Benjamin, E. J., Schulze, F., Xanthakis, V., Benndorf, R. A., & Vasan, R. S. (2009) · Circulation

Nitric Oxide and Endothelin EffectsCancer-related gene regulation

Cited by 351

Comparative effects of AT1-antagonism and angiotensin-converting enzyme inhibition on markers of inflammation and platelet aggregation in patients with coronary artery disease

Schieffer, B., Bünte, C., Witte, J., Hoeper, K., Böger, R. H., Schwedhelm, E., & Drexler, H. (2004) · Journal of the American College of Cardiology

Renin-Angiotensin System StudiesEicosanoids and Hypertension Pharmacology

Cited by 239

Association of Plasma ADMA Levels With MRI Markers of Vascular Brain Injury: Framingham Offspring Study

Pikula, A., Böger, R. H., Beiser, A. S., Maas, R., DeCarli, C., Schwedhelm, E., Himali, J. J., Schulze, F., Au, R., Kelly-Hayes, M., et al. (2009) · Stroke

Cerebrovascular and genetic disordersDementia and Cognitive Impairment Research

Cited by 85

Elevated levels of asymmetric dimethylarginine (ADMA) as a marker of cardiovascular disease and mortality

Böger, R. H., Maas, R., Schulze, F., & Schwedhelm, E. (2005) · Clinical Chemistry and Laboratory Medicine (CCLM)

Nitric Oxide and Endothelin EffectsCancer-related gene regulation

Cited by 65

The L-Arginine–Asymmetric Dimethylarginine Ratio is an Independent Predictor of Mortality in Dilated Cardiomyopathy

Anderssohn, M., Rosenberg, M., Schwedhelm, E., Zugck, C., Lutz, M., Lüneburg, N., Frey, N., & Böger, R. H. (2012) · Journal of Cardiac Failure

Nitric Oxide and Endothelin EffectsHeart Failure Treatment and Management

Cited by 44

ADMA and arginine derivatives in relation to non-invasive vascular function in the general population

Baum, C., Johannsen, S. S., Zeller, T., Atzler, D., Ojeda, F. M., Wild, P. S., Sinning, C. R., Lackner, K. J., Gori, T., Schwedhelm, E., et al. (2016) · Atherosclerosis

Nitric Oxide and Endothelin EffectsCardiovascular Health and Disease Prevention

Cited by 21